Hepion Pharmaceuticals (HEPA) COO buys 2M shares and 2M warrants
Rhea-AI Filing Summary
Hepion Pharmaceuticals, Inc. director and Chief Operating Officer Sireesh Appajosyula reported insider purchases on 2026-08-03. He acquired 2,000,000 common shares at $0.05 per share and 2,000,000 warrants with a $0.06 exercise price, expiring 2031-08-03. Following these trades, he directly owns 3,250,000 common shares and 2,000,000 warrants. The filing indicates these transactions were not made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,000,000 shares
Net Buy
2 txns
Insider
Appajosyula Sireesh
Role
Chief Operating Officer
Bought
4,000,000 shs ($100K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Warrants | 2,000,000 | $0.00 | $0.00 |
| Purchase | Common Stock | 2,000,000 | $0.05 | $100K |
Holdings After Transaction:
Warrants — 2,000,000 shares (Direct);
Common Stock — 3,250,000 shares (Direct)
Key Figures
Common shares purchased: 2,000,000 shares
Purchase price per share: $0.05 per share
Warrants acquired: 2,000,000 warrants
+3 more
6 metrics
Common shares purchased
2,000,000 shares
Common stock bought on 2026-08-03 at $0.05 per share
Purchase price per share
$0.05 per share
Price paid for 2,000,000 common shares on 2026-08-03
Warrants acquired
2,000,000 warrants
Warrants to buy common stock acquired on 2026-08-03
Warrant exercise price
$0.06 per share
Exercise price for 2,000,000 warrants expiring 2031-08-03
Warrant expiration date
2031-08-03
Expiration date of 2,000,000 warrants acquired by the COO
Common shares owned after
3,250,000 shares
Direct common stock holdings following purchases on 2026-08-03
Key Terms
exercise price, expiration date, underlying security, Rule 10b5-1 trading plan
4 terms
exercise price financial
"conversion_or_exercise_price: "0.0600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2031-08-03""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Stock""
Rule 10b5-1 trading plan regulatory
"aff_10b5_one: false indicates no Rule 10b5-1 plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
FAQ
What insider transactions did HEPA COO Sireesh Appajosyula report?
Appajosyula reported buying 2,000,000 Hepion common shares at $0.05 each and acquiring 2,000,000 warrants with a $0.06 exercise price on 2026-08-03, all held as direct ownership.
When do the newly acquired HEPA warrants held by the COO expire?
The 2,000,000 warrants acquired by the COO on 2026-08-03 carry an expiration date of 2031-08-03. They are exercisable into 2,000,000 shares of Hepion common stock at a $0.06 exercise price.
Were the HEPA COO’s Form 4 trades under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked, indicating these purchases were not reported as made under a Rule 10b5-1 trading plan. The trades are therefore not identified as pre-arranged plan transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
